Signaling cross talk between growth hormone (GH) and insulin-like growth factor-I (IGF-I) in pancreatic islet β-cells

Molecular Endocrinology

Volumn 25, Issue 12, 2011, Pages 2119-2133

  Ma, Fanxin ^a   Wei, Zhe ^a   Shi, Chunwei ^a   Gan, Yan ^a   Lu, Jia ^a   Frank, Stuart J ^b,c   Balducci, James ^a   Huang, Yao ^a  

^a ST JOSEPH'S HOSPITAL AND MEDICAL CENTER   (United States)

^b University of Alabama at Birmingham   (United States)

^c BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; JANUS KINASE 2; PROTEIN KINASE B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; STAT5 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; INTRACELLULAR SIGNALING; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; ENZYME ACTIVATION; GENE KNOCKDOWN TECHNIQUES; GROWTH HORMONE; INSULIN-LIKE GROWTH FACTOR I; INSULIN-SECRETING CELLS; JANUS KINASE 2; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; PROTEIN MULTIMERIZATION; RATS; RECEPTOR CROSS-TALK; RECEPTOR, IGF TYPE 1; RECEPTORS, SOMATOTROPIN; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR;

EID: 82055194416     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2011-1052     Document Type: Article

References (65)

1. de Koning EJ, Bonner-Weir S, Rabelink TJ 2008 Preservation of β-cell function by targeting β-cell mass. Trends Pharmacol Sci 29: 218-227
2. DeFronzo RA 2004 Pathogenesis of type 2 diabetes mellitus. Med Clin North Am 88:787-835
3. Prentki M, Nolan CJ 2006 Islet β cell failure in type 2 diabetes. J Clin Invest 116:1802-1812
4. Rhodes CJ 2005 Type 2 diabetes-a matter of cell life and death? Science 307:380-384
5. Karaca M, Magnan C, Kargar C 2009 Functional pancreatic β-cell mass: involvement in type 2 diabetes and therapeutic intervention. Diabetes Metab 35:77-84
6. Rhodes CJ 2000 IGF-I and GH post-receptor signaling mechanisms for pancreatic β-cell replication. J Mol Endocrinol 24:303-311
7. Nielsen JH, Serup P 1998 Molecular basis for islet development, growth, and regeneration. Curr Opin Endocrinol Diabetes 5:97-107
8. Nielsen JH, Galsgaard ED, Moldrup A, Friedrichsen BN, Billestrup N, Hansen JA, Lee YC, Carlsson C 2001 Regulation of cell mass by hormones and growth factors. Diabetes 50:S25-S29
9. Vasavada RC, Gonzalez-Pertusa JA, Fujinaka Y, Fiaschi-Taesch N, Cozar-Castellano I, Garcia-Ocan ̃ a A 2006 Growth factors and β cell replication. Int J Biochem Cell Biol 38:931-950
10. Favelyukis S, Till JH, Hubbard SR, Miller WT 2001 Structure and autoregulation of the insulin-like growth factor 1 receptor kinase. Nat Struct Biol 8:1058-1063
11. Laviola L, Natalicchio A, Giorgino F 2007 The IGF-I signaling pathway. Curr Pharm Des 13:663-669
12. Krishna M, Narang H 2008 The complexity of mitogen-activated protein kinases (MAPKs) made simple. Cell Mol Life Sci 65:3525-3544
13. Manning BD, Cantley LC 2007 AKT/PKB signaling: navigating downstream. Cell 129:1261-1274
14. Burks DJ, White MF 2001 β-Cell mass and function in type 2 diabetes: IRS proteins and β-cell function. Diabetes 50:S140-S145
15. Elghazi L, Bernal-Mizrachi E 2009 Akt and PTEN: β-cell mass and pancreas plasticity. Trends Endocrinol Metab 20:243-251
16. Hügl SR, White MF, Rhodes CJ 1998 Insulin-like growth factor I (IGF-I)-stimulated pancreatic β-cell growth is glucose-dependent. J Biol Chem 273:17771-17779
17. Tuttle RL, Gill NS, Pugh W, Lee JP, Koeberlein B, Furth EE, Polonsky KS, Naji A, Birnbaum MJ 2001 Regulation of pancreatic β-cell growth and survival by the serine/threonine protein kinase Akt1/PKBα. Nat Med 7:1133-1137
18. Isaksson OG, Edén S, Jansson JO 1985 Mode of action of pituitary growth hormone on target cells. Annu Rev Physiol 47:483-499
19. Frank SJ, Messina JL 2002 Growth hormone receptor. In: Oppenheim JJ, Feldman M, eds. Cytokine reference on-line. London, UK: Academic Press, Harcourt; 1-21
20. Carter-Su C, Schwartz J, Smit LS 1996 Molecular mechanism of growth hormone action. Annu Rev Physiol 58:187-207
21. Smith F, Rosen K, Villa-Komarof L, Weir GC, Bonner-Weir S 1990 Enhanced IGF-I expression in regenerating rat pancreas is localized to capillaries and proliferating duct cells. Diabetes 39(Suppl 1):66A
22. Maake C, Reinecke M 1993 Immunohistochemical localization of insulin-like growth factor 1 and 2 in the endocrine pancreas of rat, dog, and man, and their coexistence with classical islet hormones. Cell Tissue Res 273:249-259
23. Jevdjovic T, Maake C, Eppler E, Zoidis E, Reinecke M, Zapf J 2004 Effects of insulin-like growth factor-I treatment on the endocrine pancreas of hypophysectomized rats: comparison with growth hormone replacement. Eur J Endocrinol 151:223-231
24. Jevdjovic T, Maake C, Zwimpfer C, Krey G, Eppler E, Zapf J, Reinecke M 2005 The effect of hypophysectomy on pancreatic islet hormone and insulin-like growth factor I content and mRNA expression in rat. Histochem Cell Biol 123:179-188
25. Billestrup N, Nielsen JH 1991 The stimulatory effect of growth hormone, prolactin, and placental lactogen onβ-cell proliferation is not mediated by insulin-like growth factor-I. Endocrinology 129: 883-888
26. Cousin SP, Hügl SR, Myers Jr MG, White MF, Reifel-Miller A, Rhodes CJ 1999 Stimulation of pancreatic β-cell proliferation by growth hormone is glucose-dependent: signal transduction via Janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediate mitogenic signalling. Biochem J 344:649-658
27. Ashcom G, Gurland G, Schwartz J 1992 Growth hormone synergizes with serum growth factors in inducing c-fos transcription in 3T3-F442A cells. Endocrinology 131:1915-1921
28. Edmondson SR, Russo VC, McFarlane AC, Wraight CJ, Werther GA 1999 Interactions between growth hormone, insulin-like growth factor I, and basic fibroblast growth factor in melanocyte growth. J Clin Endocrinol Metab 84:1638-1644
29. Huang Y, Kim SO, Yang N, Jiang J, Frank SJ 2004 Physical and functional interaction of growth hormone and insulin-like growth factor-1 signaling elements. Mol Endocrinol 18:1471-1485
30. Gan Y, Zhang Y, Digirolamo DJ, Jiang J, Wang X, Cao X, Zinn KR, Carbone DP, Clemens TL, Frank SJ 2010 Deletion of IGF-I receptor (IGF-IR) in primary osteoblasts reduces GH-induced STAT5 signaling. Mol Endocrinol 24:644-656
31. DiGirolamo DJ, Mukherjee A, Fulzele K, Gan Y, Cao X, Frank SJ, Clemens TL 2007 Mode of growth hormone action in osteoblasts. J Biol Chem 282:31666-31674
32. McClenaghan NH 2007 Physiological regulation of the pancreatic β-cell: functional insights for understanding and therapy of diabetes. Exp Physiol 92:481-496
33. Hohmeier HE, Newgard CB 2004 Cell lines derived from pancreatic islets. Mol Cell Endocrinol 228:121-128
34. Goffin V, Shiverick KT, Kelly PA, Martial JA 1996 Sequence-function relationships within the expanding family of prolactin, growth hormone, placental lactogen, and related proteins in mammals. Endocr Rev 17:385-410
35. He K, Wang X, Jiang J, Guan R, Bernstein KE, Sayeski PP, Frank SJ 2003 Janus kinase 2 determinants for growth hormone receptor association, surface assembly, and signaling. Mol Endocrinol 17: 2211-2227
36. de Vos AM, Ultsch M, Kossiakoff AA 1992 Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255:306-312
37. Brown RJ, Adams JJ, Pelekanos RA, Wan Y, McKinstry WJ, Palethorpe K, Seeber RM, Monks TA, Eidne KA, Parker MW, Waters MJ 2005 Model for growth hormone receptor activation based on subunit rotation within a receptor dimer. Nat Struct Mol Biol 12:814-821
38. van den Eijnden MJ, Lahaye LL, Strous GJ 2006 Disulfide bonds determine growth hormone receptor folding, dimerisation and ligand binding. J Cell Sci 119:3078-3086
39. Frank SJ, Fuchs SY 2008 Modulation of growth hormone receptor abundance and function: roles for the ubiquitin-proteasome system. Biochim Biophys Acta 1782:785-794
40. Fuh G, Cunningham BC, Fukunaga R, Nagata S, Goeddel DV, Wells JA 1992 Rational design of potent antagonists to the human growth hormone receptor. Science 256:1677-1680
41. Kopchick JJ, Parkinson C, Stevens EC, Trainer PJ 2002 Growth hormone receptor antagonists: discovery, development, and use in patients with acromegaly. Endocr Rev 23:623-646
42. Zhang Y, Jiang J, Kopchick JJ, Frank SJ 1999 Disulfide linkage of growth hormone (GH) receptors (GHR) reflects GH-induced GHR dimerization. Association of JAK2 with the GHR is enhanced by receptor dimerization. J Biol Chem 274:33072-33084
43. Thirone AC, Carvalho CR, Saad MJ 2002 G120K-PEG, a human GH antagonist, decreases GH signal transduction in the liver of mice. Mol Cell Endocrinol 192:65-74
44. Huang Y, Kim SO, Jiang J, Frank SJ 2003 Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling. J Biol Chem 278:18902-18913
45. Huang Y, Li X, Jiang J, Frank SJ 2006 Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells. Oncogene 25:7565-7576
46. Li X, Huang Y, Jiang J, Frank SJ 2011 Synergy in ERK activation by cytokine receptors and tyrosine kinase growth factor receptors. Cell Signal 23:417-424
47. Luther MJ, Davies E, Muller D, Harrison M, Bone AJ, Persaud SJ, Jones PM 2005 Cell-to-cell contact influences proliferative marker expression and apoptosis in MIN6 cells grown in islet-like structures. Am J Physiol Endocrinol Metab 288:E502-E509
48. Woo D 1995 Apoptosis and loss of renal tissue in polycystic kidney diseases. N Engl J Med 333:18-25
49. He J, Bazan HE 2006 Synergistic effect of platelet-activating factor and tumor necrosis factor-α on corneal myofibroblast apoptosis. Invest Ophthalmol Vis Sci 47:883-891
50. Maurice JM, Gan Y, Ma FX, Chang YC, Hibner M, Huang Y 2010 Bupivacaine causes cytotoxicity in mouse C2C12 myoblast cells: involvement of ERK and Akt signaling pathways. Acta Pharmacol Sin 31:493-500
51. Sotiropoulos A, Ohanna M, Kedzia C, Menon RK, Kopchick JJ, Kelly PA, Pende M 2006 Growth hormone promotes skeletal muscle cell fusion independent of insulin-like growth factor 1 up-regulation. Proc Natl Acad Sci USA 103:7315-7320
52. Hansen LH, Wang X, Kopchick JJ, Bouchelouche P, Nielsen JH, Galsgaard ED, Billestrup N 1996 Identification of tyrosine residues in the intracellular domain of the growth hormone receptor required for transcriptional signaling and Stat5 activation. J Biol Chem 271:12669-12673
53. Dickson LM, Rhodes CJ 2004 Pancreatic β-cell growth and survival in the onset of type 2 diabetes: a role for protein kinase B in the Akt? Am J Physiol Endocrinol Metab 287:E192-E198
54. Sekine N, Ullrich S, Regazzi R, Pralong WF, Wollheim CB 1996 Postreceptor signaling of growth hormone and prolactin and their effects in the differentiated insulin-secreting cell line, INS-1. Endocrinology 137:1841-1850
55. Nielsen JH, Linde S, Welinder BS, Billestrup N, Madsen OD 1989 Growth hormone is a growth factor for the differentiated pancreatic β-cell. Mol Endocrinol 3:165-173
56. Harrison M, Dunger AM, Berg S, Mabley J, John N, Green MH, Green IC 1998 Growth factor protection against cytokine-induced apoptosis in neonatal rat islets of Langerhans: role of Fas. FEBS Lett 435:207-210
57. Ling Z, Hannaert JC, Pipeleers D 1994 Effect of nutrients, hormones and serum on survival of rat islet β cells in culture. Diabetologia 37:15-21
58. Ihle JN 2001 The Stat family in cytokine signaling. Curr Opin Cell Biol 13:211-217
59. Levy DE, Darnell Jr JE 2002 Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3:651-662
60. Sale EM, Sale GJ 2008 Protein kinase B: signalling roles and therapeutic targeting. Cell Mol Life Sci 65:113-127
61. Le Roith D, Bondy C, Yakar S, Liu JL, Butler A 2001 The somatomedin hypothesis: 2001. Endocr Rev 22:53-74
62. Höglund E, Mattsson G, Tyrberg B, Andersson A, Carlsson C 2009 Growth hormone increases β-cell proliferation in transplanted human and fetal rat islets. JOP 10:242-248
63. Gan Y, Shi C, Inge L, Hibner M, Balducci J, Huang Y 2010 Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells. Oncogene 29:4947-4958
64. Szot GL, Koudria P, Bluestone JA 2007 Murine pancreatic islet isolation. J Vis Exp 7:255
65. Ma F, Zhang D, Yang H, Sun H, Wu W, Gan Y, Balducci J, Wei YQ, Zhao X, Huang Y 2009 Endothelial cell-specific molecule 2 (ECSM2) modulates actin remodeling and epidermal growth factor receptor signaling. Genes Cells 14:281-293